Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative pain control with acetaminophen + ibuprofen in breast cancer surgery
KCT0010462Phase 4Not yet recruiting
- Sponsor
- Kyongbo Pharm
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetaminophen, ibuprofen in breast cancer, sponsored by Kyongbo Pharm. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
acetaminophenibuprofen
03
Conditions
breast cancer
Beyond the preview
Go deeper on KCT0010462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010462.